Status:
RECRUITING
Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)
Lead Sponsor:
CHRISTUS Health
Conditions:
Very Low Birth Weight Infant
Premature Infants
Eligibility:
All Genders
26-32 years
Phase:
NA
Brief Summary
Study focuses on determining if daily versus every-other-day (EOD) oral iron at the same dose per kilogram per day will achieve similar incidence of iron replete status at 36 weeks post-menstrual age ...
Detailed Description
Iron is an important component of hemoglobin, and an essential part of erythropoiesis. It is also a necessary micronutrient for rapidly proliferating and differentiating cells and tissues especially i...
Eligibility Criteria
Inclusion
- Children (Minor \< 18 years of age)
- Neonates
- Hospitalized
- Premature infants who are on full enteral feeds and are started on oral iron
- Premature infants who completed 26 0/7 to 32 6/7 weeks' gestation at birth
Exclusion
- • Infants with known congenital anomalies or chromosomal abnormalities (such as Trisomy 18 or Trisomy 21), conditions that affect iron metabolism (such as thalassemia or hemochromatosis), bleeding disorders or coagulopathy, and received iron parenterally prior to randomization
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 28 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06555315
Start Date
August 1 2024
End Date
March 28 2026
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRISTUS Children's
San Antonio, Texas, United States, 78207